• Colorectal Cancer
    Protocol for treatment under Hospital Exemption:T cell receptor based therapy of metastatic colorectal cancer with mRNA-engineered T cells targeting transforming growth factor beta receptor type II (TGFβII)
  • Breast Cancer
    ICON CA209-9FN: A randomized phase IIb study evaluating immunogenic chemotherapy combined with ipilimumab and nivolumab in patients with luminal B breast cancer
  • Myeloma
    A Phase IB/II Study of Cobimetinib Administered as Single Agent and in Combination With Venetoclax, With or Without Atezolizumab, in Participants With Relapsed and Refractory Multiple Myeloma


Norway Norway Sweden Finland Aarhus Herlev Copenhagen